セッション詳細
[O8]Oral Presentations 8
2025年3月19日(水) 10:45 〜 12:15
神戸国際会議場 メインホール(1F)
[O8-01]Efficacy and immunogenicity evaluation of mRNA-lipid nanoparticle vaccines for Lassa virus in surrogate mouse models of infection
Mei Hashizume1, Ayako Takashima1, *Masaharu Iwasaki1,2,3,4 (1. Research Institute for Microbial Diseases, Osaka University (Japan), 2. Center for Infectious Disease Education and Research, Osaka University (Japan), 3. Center for Advanced Modalities and Drug Delivery System, Osaka University (Japan), 4. RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan))
[O8-02]デング熱ワクチン開発での抗体依存性感染増強（ADE）の評価
Antibody-Dependent Enhancement in Dengue Vaccine Evaluations: Key Insights
*Kouichi Morita1,2, Dengue Vaccine Development Group2 (1. Nagasaki University, Dejima Infectious Disease Research Alliance (DIDA) (Japan), 2. Nagasaki University, Vaccine Research and Development Center (VRDC) (Japan))
[O8-03]Structural basis for alterations in ACE2-receptor recognition and humoral immunity evasion by SARS-CoV-2 variants
*Takao Hashiguchi1 (1. Institute for Life and Medical Sciences, Kyoto University (Japan))
[O8-04]ウイルスパンデミックを抑え込む構造生命科学
Structural life science to combat viral pandemic
*Osamu Nureki1, Kanata Matsumoto1, Yoshiaki Kise1, Yoshimasa Takahashi3, Yoshihiro Kawaoka2 (1. Graduate School of Science, The University of Tokyo (Japan), 2. The Institute of Medical Science, The University of Tokyo (Japan), 3. National Institute of Infectious Diseases (Japan))
[O8-05]実中研独自開発の遺伝子改変感染モデルマウスの紹介
Introduction of genetically modified infection model mice developed independently by CIEM
*Riichi Takahashi1 (1. Central Institute for Experimental Medicine and Life Science (Japan))
[O8-06]Clustering H5 Influenza Virus Strains Based on Amino Acid Diversity to Enhance Antibody Development for Avian Flu
*Gabriel Gonzalez1, Shinji Saito1, Koshiro Tabata1, Yukari Itakura1, Hirofumi Sawa1 (1. Institute for Vaccine Research and Development, Hokkaido University (Japan))
[O8-07]Multidimensional lipidomics approaches to explore the diversity of lipids in human PBMC subsets
*Yosuke Isobe1, Yumiko Ono1, Haruki Uchino1, Makoto Arita1 (1. RIKEN Center for Integrative Medical Sciences (Japan))
[O8-08]Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity
*Ho Namkoong1, Kyuto Sonehara2,3,4, Yoshifumi Uwamino5, Ryunosuke Saiki6, Seishi Ogawa6, Yukinori Okada2,3,4 (1. Department of Infectious Diseases, Keio University School of Medicine (Japan), 2. Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. (Japan), 3. Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan. (Japan), 4. Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. (Japan), 5. Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan. (Japan), 6. Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan. (Japan))
[O8-09]Technology development for single-cell analysis of human immune cells
*Yasuhiro Murakawa1,2 (1. RIKEN (Japan), 2. Kyoto University (Japan))